Biological Profiling of Gene Groups utilizing Gene Ontology by Blüthgen, Nils et al.
ar
X
iv
:q
-b
io
/0
40
70
34
v2
  [
q-
bio
.G
N]
  1
9 M
ay
 20
05
Biological Profiling of Gene Groups utilizing Gene Ontology
Nils Blu¨thgen1 Karsten Brand2 Branka Cˇajavec1 Maciej Swat1
Hanspeter Herzel1 Dieter Beule3
May 6, 2019
1 Humboldt University, Institute for Theoretical Biology, Invalidenstraße 43, 10115 Berlin, Germany
2Humboldt University, Department of Biology, Max-Delbru¨ck-Centrum, Robert-Ro¨ssle-Straße 10, 13125
Berlin, Germany
3 MicroDiscovery GmbH, Marienburger Straße 1, 10405 Berlin, Germany
Abstract
Increasingly used high throughput experimental techniques, like DNA or protein microarrays give as a
result groups of interesting, e.g. differentially regulated genes which require further biological interpreta-
tion. With the systematic functional annotation provided by the Gene Ontology the information required
to automate the interpretation task is now accessible. However, the determination of statistical significant
e.g. molecular functions within these groups is still an open question. In answering this question, multiple
testing issues must be taken into account to avoid misleading results. Here we present a statistical frame-
work that tests whether functions, processes or locations described in the Gene Ontology are significantly
enriched within a group of interesting genes when compared to a reference group. First we define an exact
analytical expression for the expected number of false positives that allows us to calculate adjusted p-values
to control the false discovery rate. Next, we demonstrate and discuss the capabilities of our approach us-
ing publicly available microarray data on cell-cycle regulated genes. Further, we analyze the robustness
of our framework with respect to the exact gene group composition and compare the performance with
earlier approaches. The software package GOSSIP implements our method and is made freely available at
http://gossip.gene-groups.net/.
1
1 Introduction
With the advent of genome-wide screening experi-
ments, like microarray studies [12], and 2D protein
gel analyses [16], researchers frequently face the task
of interpreting the biological function and relevance
of gene groups, e.g. groups of differentially expressed
genes. Even if the individual genes are annotated
this interpretation task remains laborious and com-
plex. Analysis of gene groups using an ontology
is a promising starting point for an automated bi-
ological profiling beyond the single-gene level. An
ontology specifies a controlled vocabulary and the
relations between the terms within the vocabulary.
This concept is widely used to systematically repre-
sent knowledge for further analysis. For molecular
biology the Gene Ontology Consortium provides the
Gene Ontology (GO) as an international standard
to annotate functions, affiliation with processes and
locations of genes and gene products [2].
We utilize GO to test whether a molecular func-
tion, biological process, or cellular location (which
we call a term in the following) is significantly asso-
ciated with a group of interesting genes. The defi-
nition of statistical significance is a major challenge
due to the large number of terms which need to be
tested. The use of single test p-values is only jus-
tified if we test whether a single term is associated
with a specific gene group. However, in genome-wide
screening experiments the situation is fundamentally
different: the current GO includes over 17700 terms,
out of which typically several thousand terms ap-
pear in the annotation of an investigated gene group
and which have to be tested. If one performs that
many tests, problems arising from multiple testing
cannot be left aside. Namely, even when we apply
a very conservative threshold like p < 0.001 a few
terms will be reported to be associated with the test
group by sheer chance. This phenomenon is known
as false positives or type-I-error. The standard so-
lution for this problem is to calculate adjusted p-
values. These adjusted p-values control the number
of false discoveries in the entire list and can be used
similar to normal p-values for single tests [10]. There
are several standard methods to calculate adjusted
p-values, like resampling and multi-step estimations.
We find that adjusted p-values obtained with stan-
dard multiple testing correction methods are unsat-
isfactory because they are either not precise enough,
or they require major computational efforts.
In this article, we present a statistical framework
and the software GOSSIP to cope with this prob-
lem. We apply a new multiple testing correction
appropriate for the problem which is based on an-
alytical results, and calculate adjusted p-values to
obtain lists of enriched GO-terms that can hint to
biological interpretation and hypothesis generation
from the results of high throughput methods. In the
following we describe our framework and compare
the multiple testing correction applied here to ear-
lier approaches. Subsequently, we investigate the ro-
bustness of our framework with respect to the exact
gene group composition. We also show the results
of our method applied to a previously published mi-
croarray experiment: namely genes that have been
found to be cell-cycle regulated in human HeLa cell
lines [17]. Further data and a heuristical approach
to determine the family wide error rate (FWER) are
discussed in the supplement [20].
2 Methods
2.1 Data preparation
In order to profile gene groups we require four data
sources: a test group of genes (e.g. up-regulated
genes), a reference group (e.g. all significantly ex-
pressed genes), GO annotations for these genes,
and the Gene Ontology. Many chip-manufacturers
provide GO annotations for the genes covered by
their chips (e.g. Affymetrix (TM), see [21]), other-
wise gene groups can be annotated using tools like
HomGL [5]. The current version of the Gene On-
tology can be downloaded from the website of the
Gene Ontology Consortium [23]. In this analysis we
used the Gene Ontology as of 11th February, 2004.
The Gene Ontology can be represented as a directed
acyclic graph (DAG) where the nodes represent the
terms [3]. Annotations are usually given as terms
within the DAG implying a series of more general
annotations upward in the GO graph, as illustrated
in Figure 1.
2.2 Statistical framework
For each term in the ontology we ask whether this
particular term is enriched in the test group as com-
pared to the reference group. To test this we cat-
egorize each gene in two ways: first, whether it is
annotated with the term under consideration or not,
and second, whether it belongs to the test group or
not. Based on these categories we build a 2 × 2
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Figure 1: Part of the directed acyclic graph (DAG)
representing the Gene Ontology. Annotations are
usually given as terms in different parts of the DAG,
e.g. term 5179 hormone activity, implying a series
of more general terms (identifiers 5102, 5488, 4871,
3674, 3673). We consider all levels of the GO graph
and our algorithm counts for each node in the DAG
how many genes in the test set and reference set are
implicitly or explicitly annotated with this term.
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Figure 2: 2×2 contingency table of gene frequency that is calculated for
each term. Each gene in categorized in two ways: whether it belongs to
the test group and whether it is annotated with the term under consid-
eration. This figure shows the contingency table for the term mitotic cell
cycle in the group of genes that are up-regulated during the G2-phase of
the cell cycle. In total, 14480 genes are in the reference group. 437 genes
are annotated with this specific term, 20 of them are in the G2-phase
gene group. 14043 are not annotated with this term. Out of this, 65 are
in the test group. The number of genes in the test group is 85.
contingency table of gene frequencies for each term.
Figure 2 shows the structure of such a contingency
table. Using Fisher’s exact test [22] we compute p-
values that allow to detect and quantify associations
between the two categorizations. Fisher’s exact test
is based on the hyper-geometric distribution, and
works in a similar way as the χ2-test for indepen-
dence. The χ2-test provides only an estimate of the
true probability values, and it is not accurate if the
marginal distribution is very unbalanced or if we ex-
pect small frequencies (less than five) in one of the
cells of the contingency table. Both situations are
typical for the task and data under consideration.
Although Fisher’s exact test can in principle quan-
tify the reduction of a term with respect to the refer-
ence group we focus on enrichment or association. A
reduction is unlikely to be detected in typical data
sets, since the test group is usually much smaller
than the reference group.
To control the number of false discoveries, we de-
termine adjusted p-values to control the false discov-
ery rate (FDR) that quantifies the expected portion
of false discoveries within the positives. If there is no
prior expectation about an association between the
gene list and any biological process, one might favor
the family-wise error rate (FWER), see [20]. How-
ever, the typical case in profiling gene lists is that
one expects some terms to be enriched. In this case
the FDR is an adequate measure of false discoveries.
Both rates can be reliably estimated by resampling
simulations, but this method suffers from very long
runtime even on modern computers. Alternatively,
several approaches exist to estimate the FDR from
the single-test p-values (e.g. Benjamini-Hochberg,
and Benjamini-Yekutieli [10]). These methods are
designed to cope with general problems but turn
out to be not particularly suitable for the specific
problem considered here. For the specific problem of
profiling gene groups, the expected number of false
discoveries (NFD) for a given p-value threshold can
be determined exactly by an analytical expression.
Consequently, we can calculate the FDR exactly.
2.3 Number of false discoveries
(NFD)
The number of genes in the reference group is de-
noted by N , the test group is a subgroup of the
reference group, with T being the number of genes
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within this group. With K we denote the number
of GO-terms which annotated genes in the reference
group. We index these GO-terms with i = 1...K,
and Zi denotes the number of genes in the reference
group being annotated by GO-term i. In the exam-
ple of Figure 2 these numbers would be: N = 14480,
T = 85, and Zi = 457.
For a given p-value threshold α we obtain the ex-
pected number of false discoveries (NFD(α)) by sum-
ming over all possible tests with weights according
to the probability of their occurrence
〈NFD(α)〉 =
K∑
i=1
Pr(pi ≤ α) . (1)
Here Pr(pi ≤ α) denotes the probability that the
unadjusted p-value of term i with its marginal dis-
tributions matches the threshold α by chance. We
use the hypergeometric distribution h(j, T,N, Zi)
h(j, T,N, Zi) =
Zi!T !(N − Zi)!(N − T )!
N !j!(Zi − j)!(T − j)!(N − Zi − T + j)!
,
(2)
to describe the probabilities of observing j anno-
tations given the marginal distribution (T,N,Zi).
Then Pr(pi ≤ α) can be calculated by
Pr(pi ≤ α) =
pf (j,T,N,Zi)≤α∑
j
h(j, T,N, Zi) , (3)
where pf(j, T,N, Zi) the p-value of the one-sided
Fisher test [22] for j or more annotations in the test
group and can be calculated by summing over the
hypergeometric distribution:
pf (j, T,N, Zi) =
min(Zj ,T )∑
k=j
h(j, T,N, Zi) . (4)
In order to validate our analytical result for
〈NFD(α)〉 we estimate the number of false discov-
eries using resampling simulations. We keep the ref-
erence group fixed with N genes and then select ran-
dom test groups of size T . The expected number of
false discoveries for a specific p-value threshold α is
estimated by the mean number of positive tests in
the resampling runs. Note that the correlations be-
tween terms induced by the structure of the graph
and by the annotation do not influence the mean
number of false discoveries but skew the distribu-
tion.
2.4 False discovery rate (FDR)
If one expects some terms to be enriched in the test
group, controlling the false discovery rate (FDR) is
the appropriate method [10]. The FDR gives an
estimate of the proportion of the expected num-
ber of false discoveries NFD(α) among all positives
R(α) for a given p-value threshold α: FDR(α) =
〈NFD(α)〉/R(α). Since we can calculate 〈NFD(α)〉
exactly, the exact determination of FDR(α) is possi-
ble, and an adjusted p-value for exact control of the
portion of false discoveries is given by pFDR(p) =
min(FDR(p), 1). Each list of terms that fulfills the
criterion pFDR(p) ≤ 0.05 is expected to contain 5%
terms that are false discoveries.
Figure 3 shows comparisons of the FDR calculated
by our methods with other approaches for data sets
described below. Our method is in excellent agree-
ment with the adjusted p-values calculated by re-
sampling simulations which provide a reliable esti-
mate of the true FDR. In the supplement [20] we
show that analytical and numerical results are in
excellent agreement for a wide range of test group
sizes and various data sets.
A particularly interesting property of this type of
curve are the sudden jumps of the FDR. These jumps
are caused by the discrete values of the p-values in
the Fisher’s exact test due to the discrete nature
of the contingency table. In the example discussed
here, some GO-terms annotate only two genes, and
their lowest possible p-value is 0.033. Therefore
these GO-terms can never be significantly enriched,
when a single-test p-value threshold is 0.03. In con-
trast to our method and the resampling simulations,
the methods according to Benjamini-Yekutieli (BY)
and Benjamini-Hochberg (BH) cannot account for
these discrete p-values. Therefore, they cannot re-
produce the sudden jumps and do not estimate the
FDR precisely for our specific problem. Some au-
thors, like the authors of FatiGO [1], try to avoid
this problem by only testing at a certain level or like
in GeneMerge [7], limit the search to terms that an-
notate two or more genes. Both approaches have
disadvantages: The first approach neglects that the
Gene Ontology is a directed, acyclic graph and the
concept of levels can only apply to trees. Addition-
ally, it is unclear whether all terms at a certain level
are similarly specific. The limitation used in the lat-
ter approach is rather arbitrary, as it is not a priori
clear, which number of genes need to be annotated
by a term that it can get significant. The resam-
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Figure 3: The adjusted p-value for the group
of genes expressed in the G2-phase of the cell
cycle in HeLa cells to control the FDR esti-
mated by our approach (solid) are in excel-
lent agreement with the resampling simula-
tions (dotted). Adjusted p-values (dashed)
with multiple step Benjamini-Hochberg and
Benjamini-Yekutieli are shown with dashed
lines.
pling simulations in Figure 3 show that the appro-
priate threshold allowing 5% false discoveries is in
this case around p=0.003. The upper limit for the
FDR provided by BY is far to conservative: if one
would allow 5% of false discoveries in Figure 3, the
single-test p-value threshold estimated by BY would
be around p=0.0005. Thus this method misses sig-
nificant results. The Bonferroni correction is even
more conservative then BY, see [20]. The estimate
provided by BH (p=0.0075) is not reliable for the
type of data under consideration, yielding more false
discoveries then specified by the threshold. Other
data sets lead to similar results concerning the per-
formance of standard multiple testing corrections,
see [20].
3 Results
3.1 Cell cycle regulated genes
Whitfield et al. [17] analyzed time series of gene
expression profiles of cell-cycle synchronized HeLa
cells leading to groups of genes exhibiting peak ex-
pression in specific phases of the cell cycle. Their
analysis yielded 874 different genes which were as-
signed to five groups of cell cycle regulated genes by
their correlation to an idealized expression profile
generated from several well studied marker genes for
G1/S-phase, S-phase, G2-phase, G2/M-phase and
M/G1-phase. The functions of the genes proposed
by this assignment procedure were found to match
published literature and other reports of cell cycle
gene expression experiments. In addition, assign-
ment of GO terms was performed. A good corre-
lation between the cell cycle phase when peak ex-
pression of a gene was observed and its assigned GO
terms was observed. However, no statistical analysis
of this correlation was performed by the authors.
In the following we applied our method to these
five published gene groups first to determine auto-
matically the GO terms which are significantly over-
represented in each of the five different gene groups,
and second to find out whether these overrepresented
GO terms match the groups function assigned by
Whitfield et al. [17]. Using HomGL [5] we could
annotate 15910 of 37137 genes on their chip with
at least one GO-Terms. This set was used as the
reference group. To reflect our prior expectation
that some cell-cycle related terms are enriched, we
used the adjusted p-value to control the FDR with a
threshold of 5% as the criterion for significance. Be-
tween 1 and 51 GO terms (mean: 28) were found to
be significant (the detailed lists of all terms and fig-
ures displaying the significant terms in the DAG can
be found in the supplement [20]. That only one sig-
nificant term in the M/G1 group was observed is not
surprising as Whitfield et al. [17] assigned here genes
to the group which are expressed during the physi-
cal act of mitosis and which are persisting into G1
phase. These genes belong to processes such as cell
adhesion or membrane trafficking which are not nec-
essarily cell cycle specific and fall into a wide range of
GO categories which therefore are not significantly
overrepresented.
To reach our second aim, we categorize all GO
terms which are significantly enriched in at least one
of the groups into four categories with respect to the
cell-cycle phases: gap phases (G), replication (R),
mitosis (M), and unspecific (U). Subsequently, we
order the GO terms which fall into the cell cycle rel-
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Table 1: Significantly enriched terms (FDR ≤ 0.05) of the five groups G1/S, S, G2, G2/M, and M/G1 that
fall into the cell cycle categories (CCC) gap phases (G), replication (R), and mitosis (M).
adjusted p-values to control FDR
for the groups according to Whitfield et.al. [17]
CCC ID GO term G1/S S G2 G2/M M/G1
G 8156 negative regulation of DNA replication 8 · 10−5
R 5659 delta DNA polymerase complex 5 · 10−4
R 6270 DNA replication initiation 2 · 10−4
G 45003 double-strand break repair via synthesis-dependent
strand annealing
1 · 10−3
G 45002 double-strand break repair via single-strand annealing 1 · 10−3
G 731 DNA repair synthesis 1 · 10−3
R 42575 DNA polymerase complex 1 · 10−3
G 724 double-strand break repair via homologous
recombination
6 · 10−3
R 3891 delta DNA polymerase activity 6 · 10−3
G 725 recombinational repair 6 · 10−3
R 3887 DNA-directed DNA polymerase activity 1 · 10−2
G 726 non-recombinational repair 2 · 10−2
R 6312 mitotic recombination 5 · 10−2
R 84 S phase of mitotic cell cycle 1 · 10−8 3 · 10−7
R 6260 DNA replication 1 · 10−8 3 · 10−7
R 30894 replisome 6 · 10−3 1 · 10−5
R 5657 replication fork 9 · 10−3 2 · 10−5
R 6261 DNA dependent DNA replication 1 · 10−8 7 · 10−4
G 6974 response to DNA damage stimulus 1 · 10−2 5 · 10−3
G 6281 DNA repair 4 · 10−3 9 · 10−3
R 3896 DNA primase activity 5 · 10−3
R 4748 ribonucleoside-diphosphate reductase activity 7 · 10−3
R 5658 alpha DNA polymerase:primase complex 7 · 10−3
R 6269 DNA replication, priming 1 · 10−2
R 5663 DNA replication factor C complex 3 · 10−2
M 7017 microtubule-based process 2 · 10−5
M 70 mitotic chromosome segregation 6 · 10−5
M 5874 microtubule 1 · 10−4
M 90 mitotic anaphase 2 · 10−4
M 30705 cytoskeleton-dependent intracellular transport 4 · 10−4
M 7018 microtubule-based movement 4 · 10−4
M 7093 mitotic checkpoint 2 · 10−3
M 7059 chromosome segregation 2 · 10−3
M 7010 cytoskeleton organization and biogenesis 9 · 10−3
M 30261 chromosome condensation 9 · 10−3
M 45298 tubulin 1 · 10−2
M 88 mitotic prophase 2 · 10−2
M 7076 mitotic chromosome condensation 2 · 10−2
M 5813 centrosome 3 · 10−2
M 922 spindle pole 4 · 10−2
M 5815 microtubule organizing center 4 · 10−2
M 7067 mitosis 9 · 10−9 6 · 10−7
M 87 M phase of mitotic cell cycle 9 · 10−9 7 · 10−7
M 15630 microtubule cytoskeleton 1 · 10−5 2 · 10−6
M 280 nuclear division 9 · 10−9 2 · 10−6
M 279 M phase 9 · 10−9 3 · 10−6
M 5819 spindle 1 · 10−2 1 · 10−5
M 775 chromosome, pericentric region 2 · 10−2 9 · 10−3
M 5856 cytoskeleton 9 · 10−3 3 · 10−2
M 7088 regulation of mitosis 1 · 10−4 1 · 10−2
M 910 cytokinesis 5 · 10−6 2 · 10−2
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evant categories gap phases, replication and mitosis
with respect to the groups of Whitfield et al. [17].
The result is shown in Table 1. Through this pro-
cedure, we can examine to which degree cell cycle
categories match the groups by Whitfield et al. The
most prominent finding is that all GO terms of the
replication category stem from the G1/S or S groups
and none of these terms originates from either the
G2/M, M, or M/G1 groups. Similarly, all terms of
the mitosis category originate from the G2, or G2/M
groups and none from G1/S or S group. Seven of the
terms which fall into the gap phase category origi-
nate from the G1/S group and another two terms are
contained in the significant terms of the G1/S and
S-phase group, while terms from all groups are found
in the unspecific cell cycle group (see Table 1 of [20]).
In conclusion we can confirm that the terms that are
significant in our analysis provide a reasonable bio-
logical characterization of the gene groups suggest by
Whitfield et al. [17]. We can clearly separate mitosis
and replication. In addition, our analysis indicates
the close relationship of G2- and M-phase, and G1-
and S-phase respectively. This example shows that
our method can provide useful functional character-
ization of a given gene group without using prior
knowledge. For further examples refer to the sup-
plement [20].
3.2 Robustness of biological profiles
When extracting a gene group from high-throughput
experiments, one always has to deal with the trade-
off between specificity and sensitivity. By increasing
the group size, an increased portion of genes is in-
cluded in the group just by chance and not due to
biological or functional reasons. Therefore it is often
not clear which genes to include in or exclude from a
certain gene group, e.g. by choosing a specific thresh-
old. In principle these falsely assigned genes might
result in falsely discovered GO terms.
In the following we show that the results of our
method do not depend critically on the precise com-
position of the test group, and are robust with re-
spect to a high portion of genes which are acciden-
tally assigned to the group. Here we assume that
the falsely assigned genes are randomly distributed
on the microarray. This assumption does not neces-
sarily hold for gene lists obtained with rather naive
microarray analysis, since e.g. the absolute signal or
cross hybribridization might induce a bias. However,
there are approaches to limit such a bias, for example
by estimating the variance for each gene from repli-
cations [11], or by variance stabilization [14]. We
address the robustness by profiling the gene group
of 221 cell-cycle regulated genes expressed in the S-
phase [17], and adding randomly selected genes to
this group. Initially, 37 terms are reported to be sig-
nificant (FDR<0.05). Subsequently 10, 20, 50, 100,
200, 500, and 750 randomly selected genes from the
reference group are added to the initial test group
and the resulting groups are profiled. We repeated
this procedure 100 times and determined how much
of the initial profile is preserved. Figure 4A shows
that the number of significantly enriched terms de-
creases if we add more and more random genes.
However, the profile is remarkable robust: even if we
add 200 randomly selected genes, we can still detect
17 of the initially 37 significant terms. Interestingly,
from the difference between the solid and dashed line
we see that only about 5% of the terms in the result-
ing profiles are not contained in the initial profile for
the S-phase, regardless of the number of randomly
selected genes added. These are potentially falsely
discovered terms confirming our criterion of the ad-
justed p-value to control the FDR<0.05. Figure 4B
shows the robustness of terms with different initial
FDR. As expected, terms with a FDR just below
the threshold of 0.05, like adenyl nucleotide bind-
ing (id 30554, FDR=0.044), are unlikely to be de-
tected after adding many randomly selected genes.
However, terms with intermediate significance, like
nucleosome assembly (id 6334, FDR=0.0091), and
DNA repair (id 6281, FDR=0.00099), can still be
detected nearly always after adding 100 randomly
selected genes. Remarkably, highly significant terms
like DNA metabolism, (id 6259, FDR=5.2·10−8), are
found in 99% of all cases even after adding 500 ran-
domly selected genes. These results show that our
framework performs reasonably well even if many
randomly selected genes are in the gene groups. Es-
pecially intermediate and highly significant terms
will persist. Furthermore, the framework controls
the number of falsely discovered terms reliably.
4 Discussion
In this study we propose a statistical framework to
find molecular functions, biological processes and
cellular locations significantly associated with gene
groups. Our approach allows an unbiased biologi-
cal profiling of gene groups beyond the single gene
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Figure 4: The effect of adding randomly selected genes to the test group: to the gene group of cell-cycle
regulated genes expressed in the S-phase (221 genes), we add randomly 10, 20, 50, 100, 200, 500 and 750
genes from the reference group and profile these gene groups. (A) The solid line shows the mean number
of significant terms in 100 runs. The dashed line displays the number of those terms, which are significant
in the initial group. The dotted line shows the difference between both lines in percent. (B) Percentage of
runs where the terms with identifier 30554, 6334, 6281 and 6259 are still detected as significant.
level. We pay special attention to the multiple test-
ing problem, and we give an exact determination of
the expected number of false discoveries. We val-
idate our framework with resampling simulations,
and find that we can calculate adjusted p-values as
reliable as with resampling simulations. Adjusted p-
values can differ from the single test p-values by a
factor of more than 104. In contrast to resampling
simulations, which are very slow (up to hours), our
approach needs just a few seconds. Comparison with
our approach shows that the method of Benjamini-
Yekutieli is too conservative, resulting in adjusted
p-values which are typically 2-6 times higher. Thus,
this methods would miss many significant results.
The Benjamini-Hochberg estimate is not reliable for
the problem under consideration.
Furthermore, we show that our method is robust
with respect to randomly assigned genes in the gene
groups. Therefore the biological profiles do not de-
pend critically on the details of the prior analysis
yielding the groups, e.g. threshold, parameters of
cluster analysis methods, and normalizations. For
the cell-cycle data of Ref. [17] we demonstrate that
the profiles allow a reasonable biological interpreta-
tion of the gene groups. No clearly irrelevant terms
are reported. The fact that we can separate mito-
sis and replication confirms the initial grouping by
Whitfield et al. [17] Therefore, we conclude that our
framework is indeed sensitive enough to find the rel-
evant biological profiles in gene groups.
Additionally, our framework has been applied to
predict the functional targets of transcription factors
by profiling gene lists that display clusters of bind-
ing sites in their upstream regions [6, 15]. Although
the gene groups that display clusters of binding sites
are dominated by non-functional sites, the rigorous
statistics allows to make reliable predictions for the
true functional targets. The example studied in this
paper and in the supplement [20] illustrate that the
combination of high-throughput technologies, Gene
Ontology, and a careful statistical analysis can auto-
mate the complex and laborious task of understand-
ing the function of gene groups.
There are several software implementations avail-
able to profile gene groups using Gene Ontology, in-
cluding Onto-Express [9], EASE+David [8, 13], Go-
Surfer [19], GoMiner [18], GeneMerge [7], FatiGO
[1], and GOstat [4]. The software packages listed
before, with the exception of Onto-Express (free ver-
sion) and GoMiner, have some multiple testing cor-
rection. We conclude from our studies, that results
of applications that do not use multiple testing cor-
rections (Onto-Express and GoMiner) are hard to
be interpreted since here false positive predictions
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will dominate. On the other hand, the packages us-
ing appropriate standard multiple testing corrections
(Bonferroni in Gene Merge, Benjamini-Yekutieli in
FatiGo, GoStat, GOSurfer) do give control of the
number of false discoveries, but are too conservative,
and therefore have less power. Only EASE+David
uses a jackknife procedure similar to resampling to
correct for multiple testing, which can give more ro-
bust scores, although they cannot be interpreted as
adjusted p-values. A software package (GOSSIP)
for profiling gene groups that uses our method and
visualizes the results is made freely available at [20].
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